Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06993038 · ClinicalTrials.gov registry record · Phase 4
Adenosine vs Diltiazem for Treatment of SVT in the ED
A Phase 4 study of Supraventricular Tachycardia (SVT), sponsored by Anne E. Zepeski.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06993038: Recruiting Phase 4 study of Supraventricular Tachycardia (SVT), sponsored by Anne E. Zepeski.
NCT06993038 is a Phase 4 study of Supraventricular Tachycardia (SVT) that is actively recruiting participants, run by Anne E. Zepeski. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06993038, a Phase 4 study of Supraventricular Tachycardia (SVT), is actively recruiting participants, sponsored by Anne E. Zepeski.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Primary Outcome
Patients with stable SVT are identified in the ED (Threshold \>90%)
Conditions Studied
Interventions
- DRUG adenosine
- DRUG diltiazem
Study Locations (1)
Iowa
- University of Iowa Health Care - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
What NCT06993038 shows while recruiting
NCT06993038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Supraventricular Tachycardia (SVT) appearing as the primary indexed condition, and to 2 interventions - of which adenosine is the first listed.
NCT06993038 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06993038 about?
NCT06993038 is a clinical study titled "Adenosine vs Diltiazem for Treatment of SVT in the ED". This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
What is the current status of trial NCT06993038?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2025-08-01. Estimated completion is 2026-12.
What conditions does trial NCT06993038 study?
This clinical trial studies the following conditions: Supraventricular Tachycardia (SVT).
What interventions are being tested in trial NCT06993038?
The interventions under investigation include: adenosine (DRUG), diltiazem (DRUG).
Who is sponsoring clinical trial NCT06993038?
This trial is sponsored by Anne E. Zepeski, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06993038 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supraventricular Tachycardia (SVT)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06993038's enrollment target sits among peer trials
20 1753rd of 2000 higher than 168 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI